hrp0098p3-32 | Bone, Growth Plate and Mineral Metabolism | ESPE2024

Growth hormone treatment in a case of cleidocranial dysplasia with growth hormone deficiency

Jun Jung Hyeon , Lyeon Kim Goo , Yu Jeesuk

Backgound: Cleidocranial dysplasia (CCD) is a rare genetic disorder characterized by skeletal abnormalities affecting various parts of the body, including the skull, clavicles, and long bones. The responsible gene is RUNX2 which plays a crucial role in the development of bone and cartilage. Sometimes growth hormone deficiency (GHD) can be associated with short stature in CCD.Case: A female patient was brought to...